Signal-to-noise ratios at 1 and 3 years (change from placebo group; CV from all patients)
| Lipid | Signal | Noise | Signal-to-noise ratio | Rank | ||
|---|---|---|---|---|---|---|
| Change from year 0 | CV | Change/CV | ||||
| Year 1 | Year 3 | Year 1 | Year 3 | |||
| Total cholesterol (mmol/L) | 0.13 | 0.24 | 0.30 (10) | 0.43 (0.38–0.51) | 0.80 (0.73–0.89) | 8 |
| LDL cholesterol (mmol/L) | 0.08 | 0.17 | 0.25 (13) | 0.31 (0.26–0.39) | 0.70 (0.61–0.78) | 10 |
| HDL cholesterol (mmol/L) | 0.01 | 0.01 | 0.013 (12) | 0.54 (0.44–0.63) | 0.97 (0.85–1.09) | 3 |
| Total to HDL cholesterol ratio | 0.37 | 0.86 | 0.63 (13) | 0.59 (0.53–0.70) | 1.37 (1.31–1.50) | 1 |
| LDL to HDL cholesterol ratio | 0.22 | 0.54 | 0.42 (15) | 0.53 (0.46–0.64) | 1.29 (1.25–1.47) | 2 |
| Non-HDL cholesterol (mmol/L) | 0.14 | 0.22 | 0.27 (11) | 0.52 (0.45–0.70) | 0.82 (0.73–0.89) | 6 |
| Triglycerides (mmol/L) | 0.23 | 0.42 | 0.37 (34) | 0.37 (0.29–0.53) | 0.88 (0.73–0.89) | 5 |
| Apolipoprotein A1 (g/L) | 0.01 | 0.02 | 0.02 (11) | 0.33 (0.28–0.39) | 0.77 (0.68–0.86) | 9 |
| Apolipoprotein B (g/L) | 0.01 | 0.02 | 0.03 (12) | 0.52 (0.38–0.62) | 0.82 (0.69–0.93) | 6 |
| Apolipoprotein B/A1 | 0.01 | 0.01 | 0.02 (13) | 0.45 (0.37–0.58) | 0.89 (0.77–1.08) | 4 |
CV, coefficient of variation; HDL, high-density lipoprotein; LDL, low-density lipoprotein.